Phibro Animal Health CorporationPAHCNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank54
3Y CAGR-19.2%
5Y CAGR-13.3%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-19.2%/yr
Quarterly compound
5Y CAGR
-13.3%/yr
Recent deceleration
Percentile
P54
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.75% |
| Q3 2025 | -3.91% |
| Q2 2025 | 8.88% |
| Q1 2025 | 12.47% |
| Q4 2024 | 18.75% |
| Q3 2024 | -4.66% |
| Q2 2024 | 3.78% |
| Q1 2024 | 5.31% |
| Q4 2023 | 8.04% |
| Q3 2023 | -9.29% |
| Q2 2023 | 3.82% |
| Q1 2023 | 0.42% |
| Q4 2022 | 5.21% |
| Q3 2022 | -8.91% |
| Q2 2022 | 6.53% |
| Q1 2022 | 2.97% |
| Q4 2021 | 8.41% |
| Q3 2021 | -2.55% |
| Q2 2021 | 4.04% |
| Q1 2021 | 2.71% |
| Q4 2020 | 5.61% |
| Q3 2020 | 5.01% |
| Q2 2020 | -11.79% |
| Q1 2020 | -1.53% |
| Q4 2019 | 12.80% |
| Q3 2019 | -6.95% |
| Q2 2019 | -0.89% |
| Q1 2019 | -5.72% |
| Q4 2018 | 9.03% |
| Q3 2018 | -5.50% |
| Q2 2018 | 1.38% |
| Q1 2018 | 1.47% |
| Q4 2017 | 6.44% |
| Q3 2017 | -0.71% |
| Q2 2017 | 2.60% |
| Q1 2017 | -0.91% |
| Q4 2016 | 1.92% |
| Q3 2016 | -0.64% |
| Q2 2016 | 3.13% |
| Q1 2016 | -4.33% |